[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542669":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":41,"locations":48,"responsibleParty":66,"collaborators":68,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":26,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":82,"minAge":83,"maxAge":26,"enrollmentInfo":84,"targetDuration":26,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":95,"overallStatus":50,"whyStopped":26,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"University of South Florida","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental","EXPERIMENTAL","8 weeks of online CBT-I (1 session\u002Fweek for 1 hour), followed by tapered withdrawal and motivational interviewing and check-ins.",[13,14],"Behavioral: CBT-I","Other: Tapered Withdrawal",{"label":16,"type":6,"description":17,"interventionNames":18},"Treatment as usual","Continuation of standard treatment for sleep and pain for 8 weeks, followed by tapered withdrawal and motivational interviewing and check-ins.",[19,14],"Behavioral: Treatment as usual",[21,27,30],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","CBT-I","Includes 8 weekly sessions of CBT-I and 2 bi-monthly boosters. Each session is to be completed individually by the participant in a single sitting (less than 45 mins). Each session should be completed in 7 days with next session released only after prior one completed.",[9],null,{"type":22,"name":16,"description":28,"armGroupLabels":29,"otherNames":26},"Includes 8 weekly sessions of standard treatment and 2 bi-monthly boosters. Each session is to be completed individually by the participant in a single sitting (less than 45 mins). Each session should be completed in 7 days with next session released only after prior one completed.",[16],{"type":6,"name":31,"description":32,"armGroupLabels":33,"otherNames":26},"Tapered Withdrawal","Individualized gradual tapered withdrawal following CDC guidelines, additional check-ins and motivational interviewing with a therapist.",[9,16],[35,38],{"name":36,"affiliation":5,"role":37},"Christina S McCrae, PhD","PRINCIPAL_INVESTIGATOR",{"name":39,"affiliation":5,"role":40},"Britani Holland, PhD","STUDY_DIRECTOR",[42,46],{"name":36,"role":43,"phone":44,"phoneExt":26,"email":45},"CONTACT","8139741804","christinamccrae@usf.edu",{"name":39,"role":43,"phone":44,"phoneExt":26,"email":47},"blalone@usf.edu",[49],{"facility":5,"status":50,"city":51,"state":52,"zip":53,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"RECRUITING","Tampa","Florida","33612","United States","US",{"type":57,"coordinates":58},"Point",[59,60],-82.45843,27.94752,{"lat":60,"lon":59},[63,65],{"name":36,"role":43,"phone":64,"phoneExt":26,"email":45},"813-974-1804",{"name":39,"role":43,"phone":44,"phoneExt":26,"email":47},{"type":67,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[69,72],{"name":70,"class":71},"National Institutes of Health (NIH)","NIH",{"name":73,"class":71},"National Institute on Drug Abuse (NIDA)","100542669","improving-sleep-and-reducing-opioid-use-in-individuals-with-chronic-pain-100542669",false,"NCT06345872","Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain","SPIN Opioid: Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain","Inclusion Criteria:\n\n* 18+ yrs\n* willing to be randomized,\n* can read\u002Funderstand English\n* diagnosed with chronic widespread pain and insomnia (as described below)\n* prescribed opioid medication for 1+ mo, 3+ times per week\n* desire to reduce or eliminate opioid use\n* written agreement from physician prescribing opioid medication\n* no prescribed or OTC sleep meds for 1+ mo, or stabilized on meds for 6+ wks\n\nExclusion Criteria:\n\n* unable to provide informed consent\n* cognitive impairment (MMSE \\\u003C26)\n* sleep disorder other than insomnia \\[i.e., sleep apnea (apnea\u002Fhypopnea index, AHI \\>15)\n* Periodic Limb Movement Disorder (myoclonus arousals per hour \\>15)\\]\n* bipolar or seizure disorder (due to risk of sleep restriction treatment)\n* other severe, untreated major psychopathology except for depression or anxiety (e.g.,suicidal ideation\u002Fintent, psychotic disorders)\n* psychotropic or other medications (e.g., beta-blockers) that alter pain or sleep (medications prescribed for pain or sleep are allowed)\n* participation in other non-pharmacological treatment for pain, sleep, or mood outside the current trial\n* internal metal objects or electrical devices\n* pregnancy\n* presumptive\u002Fconfirmed lumbar nerve root compression\n* confirmed lumbar spinal stenosis\n* \\\u003C6 mos post-back surgery\n* other spinal disorders",true,"ALL","18 Years",{"count":85,"type":86},165,"ESTIMATED","INTERVENTIONAL",[89],"NA","The goal of this study is to test two behavioral interventions for chronic insomnia in individuals with chronic pain and use prescribed opioid medication to treat their chronic pain.",[92,93,94],"Chronic Pain","Chronic Insomnia","Opioid Use",[96,97,98,23],"Chronic pain","Chronic insomnia","Opioid use","2026-04-17",{"date":101,"type":102},"2026-04-21","ACTUAL",{"date":104,"type":102},"2024-12-11",{"date":106,"type":86},"2028-07-01",{"name":5,"class":6},1]